Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Mallinckrodt
Cerilliant
Dow
Boehringer Ingelheim
Colorcon
Julphar
McKinsey
Fuji

Generated: April 22, 2018

DrugPatentWatch Database Preview

AKPRO Drug Profile

« Back to Dashboard

When do Akpro patents expire, and what generic alternatives are available?

Akpro is a drug marketed by Akorn and is included in one NDA.

The generic ingredient in AKPRO is dipivefrin hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
Drug patent expirations by year for AKPRO
Synonyms for AKPRO
(+-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol 3,4-dipivalate hydrochloride
(1)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylene dipivalate hydrochloride
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate hydrochloride
019D938
1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol hydrochloride
2-[(2,2-dimethylpropanoyl)oxy]-4-[1-hydroxy-2-(methylamino)ethyl]phenyl 2,2-dimethylpropanoate hydrochloride
2-{3,4-bis[(2,2-dimethylpropanoyl)oxy]phenyl}-2-hydroxy-N-methylethanaminium chloride
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate) hydrochloride
64019-93-8
AC1L2G8U
AC1Q60VF
AN-38853
API0006667
C19H29NO5.HCl
C19H30ClNO5
CAS-64019-93-8
CCG-220632
CHEBI:4647
CHEMBL1200833
D01017
Dipivalyl epinephrine hydrochloride
Dipivefrin HCL
Dipivefrin hydrochloride
Dipivefrin hydrochloride (JAN/USP)
Dipivefrin hydrochloride [USAN:JAN]
Dipivefrin hydrochloride [USP:JAN]
dipivefrine HCl
Dipivefrine hydrochloride
DSSTox_CID_25494
DSSTox_GSID_45494
DSSTox_RID_80914
DTXSID2045494
EINECS 264-609-5
HMS1569P06
LS-121420
MLS002153922
MolPort-001-540-620
NCGC00016906-01
Propanoic acid, 2,2-dimethyl-, 4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylene ester, hydrochloride, (+-)-
Propanoic acid, 2,2-dimethyl-, 4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylene ester,hydrochloride, (+-)-
Propine (TN)
SCHEMBL41350
SMR001233266
Tox21_110675
V0312
VKFAUCPBMAGVRG-UHFFFAOYSA-N

US Patents and Regulatory Information for AKPRO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn AKPRO dipivefrin hydrochloride SOLUTION/DROPS;OPHTHALMIC 074382-001 Sep 29, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Teva
McKesson
McKinsey
Deloitte
Cipla
Harvard Business School
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.